NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $895,058 | -18.0% | 1,273,379 | +163.7% | 0.01% | -35.0% |
Q4 2022 | $1,091,370 | -28.0% | 482,907 | +1.9% | 0.02% | -31.0% |
Q3 2022 | $1,516,000 | -18.1% | 473,751 | -2.7% | 0.03% | -43.1% |
Q2 2022 | $1,850,000 | -8.4% | 486,724 | +29.9% | 0.05% | -5.6% |
Q1 2022 | $2,020,000 | +759.6% | 374,700 | +2765.8% | 0.05% | +671.4% |
Q3 2021 | $235,000 | -36.0% | 13,075 | -39.5% | 0.01% | -72.0% |
Q4 2020 | $367,000 | -69.0% | 21,607 | -66.8% | 0.02% | -64.8% |
Q3 2019 | $1,184,000 | – | 65,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |